SPESOLIMAB Pharmacologic Class Indexing
- Class set ID
- 448fa42a-a0a7-4aa1-85d7-0a46b3d67c97
- Version
- 1
- Effective date
- 20230707
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use SPEVIGO safely and effectively. See full prescribing information for SPEVIGO. SPEVIGO ® (spesolimab-sbzo) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2022 | LEO Pharma Inc. | Boehringer Ingelheim Pharma GmbH and Co. KG | West-Ward Columbus Inc. | 20260316 | 2 |
| These highlights do not include all the information needed to use SPEVIGO safely and effectively. See full prescribing information for SPEVIGO. SPEVIGO ® (spesolimab-sbzo) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim Pharma GmbH and Co. KG | West-Ward Columbus Inc. | 20251027 | 6 |